A carregar...
Could the Drug Tafenoquine Revolutionize Treatment of Babesia microti Infection?
BACKGROUND: Tafenoquine (TQ) was recently approved by the US Food and Drug Administration for prophylaxis of malaria and, in addition, for eradication of the hepatic phase of the relevant Plasmodium species. In this study, we evaluated the efficacy of TQ for treatment of Babesia microti infection in...
Na minha lista:
| Publicado no: | J Infect Dis |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6603973/ https://ncbi.nlm.nih.gov/pubmed/31099380 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jiz119 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|